Close

Sanofi Files For Hart-Scott-Rodino Notification Regarding Proposed Acquisition Of Medivation

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Growth Factors Shaping the Biologics CDMO Service Market

The Biologics Clinical Manufacturing CDMO Service market has progressed...

CDMO Market For Small Molecule Innovation Soars By 2033

It has been anticipated that the market for contract...

API Sourcing Redefining Global Pharmaceutical Supply Chain

The COVID-19 pandemic went on to expose crucial susceptibility...

Pharmaceutical Fine Chemicals Market to hit $235bn by 2030

The pharmaceutical fine chemicals market is all set for...

Sanofi Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Medivation

Sanofi announced that it has filed for premerger notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) with the U.S. Department of Justice Antitrust Division and the Federal Trade Commission regarding its intention to acquire Medivation, Inc. (NASDAQ: MDVN).  As announced on April 28, 2016, Sanofi proposed to acquire Medivation for $52.50 per share, representing an all-cash transaction valued at approximately $9.3 billion.

About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris

Media Relations
Jack Cox and Laurence Bollack
Tel. : +33 (0)1 53 77 46 46
mr@sanofi.com

Investor Relations
Sébastien Martel
Tel.: +33 (0)1 53 77 45 45

George Grofik
Tel.: + 1 908-981-5560
ir@sanofi.com

 

Latest stories

Related stories

Growth Factors Shaping the Biologics CDMO Service Market

The Biologics Clinical Manufacturing CDMO Service market has progressed...

CDMO Market For Small Molecule Innovation Soars By 2033

It has been anticipated that the market for contract...

API Sourcing Redefining Global Pharmaceutical Supply Chain

The COVID-19 pandemic went on to expose crucial susceptibility...

Pharmaceutical Fine Chemicals Market to hit $235bn by 2030

The pharmaceutical fine chemicals market is all set for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back